These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12721555)

  • 41. The fit between organic and pharma crops in North Carolina.
    Williams CG
    Nat Biotechnol; 2007 Feb; 25(2):166-7; discussion 167. PubMed ID: 17287742
    [No Abstract]   [Full Text] [Related]  

  • 42. Italy employs further GMO delay tactics.
    Meldolesi A
    Nat Biotechnol; 2003 Apr; 21(4):346. PubMed ID: 12665808
    [No Abstract]   [Full Text] [Related]  

  • 43. Ecological risk assessment for Bt crops.
    Andow DA; Lövei GL; Arpaia S
    Nat Biotechnol; 2006 Jul; 24(7):749-51; author reply 751-3. PubMed ID: 16841050
    [No Abstract]   [Full Text] [Related]  

  • 44. [Biotechnology in the modern world: benefits and risks].
    Blium IaB
    Tsitol Genet; 2002; 36(1):59-79. PubMed ID: 12012599
    [No Abstract]   [Full Text] [Related]  

  • 45. Agricultural biotech: the rice squad.
    Surridge C
    Nature; 2002 Apr; 416(6881):576-8. PubMed ID: 11948321
    [No Abstract]   [Full Text] [Related]  

  • 46. US reflects on flying eye for transgenic crops.
    Knight J
    Nature; 2003 Sep; 425(6954):112. PubMed ID: 12968141
    [No Abstract]   [Full Text] [Related]  

  • 47. US Presidential transition prompts biotech policy frenzy.
    Fox JL
    Nat Biotechnol; 2001 Mar; 19(3):183-4. PubMed ID: 11231515
    [No Abstract]   [Full Text] [Related]  

  • 48. Is Bt better?
    Environ Health Perspect; 1997 May; 105(5):472-3. PubMed ID: 9222128
    [No Abstract]   [Full Text] [Related]  

  • 49. Science-free GM good tests advance.
    Peerenboom E
    Nat Biotechnol; 1998 Aug; 16(8):712-3. PubMed ID: 9702761
    [No Abstract]   [Full Text] [Related]  

  • 50. Puzzling industry response to ProdiGene fiasco.
    Fox JL
    Nat Biotechnol; 2003 Jan; 21(1):3-4. PubMed ID: 12511893
    [No Abstract]   [Full Text] [Related]  

  • 51. Firms sleuth out transgenic foods.
    Steinberg D
    Nat Biotechnol; 1997 Dec; 15(13):1331-2. PubMed ID: 9415876
    [No Abstract]   [Full Text] [Related]  

  • 52. Environment regulations hinder biotech industry.
    Miller HI
    Nature; 2000 Aug; 406(6796):560. PubMed ID: 10949276
    [No Abstract]   [Full Text] [Related]  

  • 53. Green energy. The promise of drought-tolerant corn.
    Service RF
    Science; 2009 Oct; 326(5952):517. PubMed ID: 19900877
    [No Abstract]   [Full Text] [Related]  

  • 54. Superweed study falters as seed firms deny access to transgene.
    Dalton R; Diego S
    Nature; 2002 Oct; 419(6908):655. PubMed ID: 12384660
    [No Abstract]   [Full Text] [Related]  

  • 55. A meta-analysis of effects of Bt cotton and maize on nontarget invertebrates.
    Marvier M; McCreedy C; Regetz J; Kareiva P
    Science; 2007 Jun; 316(5830):1475-7. PubMed ID: 17556584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ecology. New corn plant draws fire from GM food opponents.
    Ferber D
    Science; 2000 Feb; 287(5457):1390. PubMed ID: 10722381
    [No Abstract]   [Full Text] [Related]  

  • 57. The biotechnology revolution and its regulatory evolution.
    Hoffman DE
    Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
    [No Abstract]   [Full Text] [Related]  

  • 58. Report recommends ban of US GM maize in Mexico.
    Fox JL
    Nat Biotechnol; 2005 Jan; 23(1):6. PubMed ID: 15637599
    [No Abstract]   [Full Text] [Related]  

  • 59. Consuming (f)ears of corn: public health and biopharming.
    Bratspies RM
    Am J Law Med; 2004; 30(2-3):371-404. PubMed ID: 15382759
    [No Abstract]   [Full Text] [Related]  

  • 60. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.